arXiv Science⌕ Search

arXiv subjects

Sultan Mahmud

Publications and source records attributed to Sultan Mahmud.

3 recordsLinked to original sources

HDR-DTCP: High-Dynamic-Range Differential Tissue-Coupled Wireless Powering for Tunable Biphasic Stimulation in Injectable Implants

Next-generation implantable neurostimulators require efficient wireless power delivery in smaller, less invasive form factors, yet variations in tissue coupling, implantation conditions, and stimulation loads can alter received power (or requirements) and degrade energy-harvesting performance. This work presents high-dynamic-range (HDR) differential tissue-coupled powering (DTCP), termed HDR-DTCP, a body-coupled architecture in which noninvasive differential electrodes establish an AC electric field in tissue and a thread-like implant extracts power from the longitudinal potential gradient for on-chip harvesting and stimulation. Distributed coupling along the implant length, rather than receiver cross-section, enables minimally invasive injectable geometries, with harvested power scaling with implant length. A 65-nm complementary metal-oxide-semiconductor (CMOS) prototype integrates a reconfigurable four-stage energy harvester with automatic stage selection and a tunable constant-current biphasic stimulator, achieving 63.5\% peak power-conversion efficiency (PCE) at $-16.3$ dBm and $>50\%$ PCE over a 9-dB input-power range. Preliminary in-vivo validation of DTCP was done with a second application-specific integrated circuit (ASIC) on an injectable flexible substrate, capable of being delivered through a 14-gauge needle adjacent to the sciatic nerve of Sprague-Dawley rats (n=4). External copper-pad DTCP powering evoked repeatable hind-limb twitches and electromyography (EMG) response; ultrasound confirmed sub-millimeter nerve proximity, video-based paw-tip tracking captured the response, and 8-day post-implant dissection verified placement along the sciatic-nerve trajectory. Overall, this work provides an integrated wireless powering, energy-harvesting, and stimulation platform toward fully battery-free injectable neuromodulation implants.

eess.SP↗

BlueME: Robust Underwater Robot-to-Robot Communication Using Compact Magnetoelectric Antennas

We present the design, development, and experimental validation of BlueME, a compact magnetoelectric (ME) antenna array system for underwater robot-to-robot communication. BlueME employs ME antennas operating at their natural mechanical resonance frequency to efficiently transmit and receive very-low-frequency (VLF) electromagnetic signals underwater. We outline the design, simulation, fabrication, and integration of the proposed system on low-power embedded platforms, focusing on portable and scalable applications. For performance evaluation, we deployed BlueME on an autonomous surface vehicle (ASV) and a remotely operated vehicle (ROV) in open-water field trials. Ocean trials demonstrate that BlueME maintains reliable signal transmission at distances beyond 700 meters while consuming only 10 watts of power. Field trials show that the system operates effectively in challenging underwater conditions such as turbidity, obstacles, and multipath interference -- conditions that generally affect acoustics and optics. Our analysis also examines the impact of complete submersion on system performance and identifies key deployment considerations. This work represents the first practical underwater deployment of ME antennas outside the laboratory and implements the largest VLF ME array system to date. BlueME demonstrates significant potential for marine robotics and automation in multi-robot cooperative systems and remote sensor networks.

cs.RO↗

Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh

A total of 605 eligible respondents took part in this survey (population size 1630046161 and required sample size 591) with an age range of 18 to 100. A large proportion of the respondents are aged less than 50 (82%) and male (62.15%). The majority of the respondents live in urban areas (60.83%). A total of 61.16% (370/605) of the respondents were willing to accept/take the COVID-19 vaccine. Among the accepted group, only 35.14% showed the willingness to take the COVID-19 vaccine immediately, while 64.86% would delay the vaccination until they are confirmed about the vaccine s efficacy and safety or COVID-19 becomes deadlier in Bangladesh. The regression results showed age, gender, location (urban/rural), level of education, income, perceived risk of being infected with COVID-19 in the future, perceived severity of infection, having previous vaccination experience after age 18, having higher knowledge about COVID-19 and vaccination were significantly associated with the acceptance of COVID-19 vaccines. The research reported a high prevalence of COVID-19 vaccine refusal and hesitancy in Bangladesh.

cs.CY↗